Fasting plasma glucose variability levels and risk of adverse outcomes among patients with type 2 diabetes: A systematic review and meta-analysis
Diabetes Research and Clinical Practice Feb 24, 2019
Zhao Q, et al. - In patients with type 2 diabetes, researchers evaluated the correlation between fasting plasma glucose (FPG) variability levels and the risk of retinopathy and all-cause mortality via studies found on PubMed and EMBASE. The relationship between all-cause mortality and FPG variability was not significant for median or mean FPG variability under 20%. According to this systematic review and meta-analysis, in type 2 diabetes patients, high FPG variability levels were positively related to the risk of retinopathy and all-cause mortality.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries